Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.76 SEK 0.78% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vicore Pharma Holding AB
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
PP&E Net
kr10k
CAGR 3-Years
-74%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
PP&E Net
kr213.3m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
PP&E Net
kr20.6m
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
PP&E Net
kr391m
CAGR 3-Years
35%
CAGR 5-Years
17%
CAGR 10-Years
16%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
PP&E Net
kr384m
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
13%
BioArctic AB
STO:BIOA B
PP&E Net
kr31.1m
CAGR 3-Years
-8%
CAGR 5-Years
27%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.8B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.86 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's PP&E Net?
PP&E Net
10k SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's PP&E Net amounts to 10k SEK.

What is Vicore Pharma Holding AB's PP&E Net growth rate?
PP&E Net CAGR 5Y
-53%

Over the last year, the PP&E Net growth was -74%. The average annual PP&E Net growth rates for Vicore Pharma Holding AB have been -74% over the past three years , -53% over the past five years .

Back to Top